Financials
- Market Capitalization 2.1 B
- Employee 398
- Founded 1989
- CEO Nick Colangelo
- Website www.vcel.com
- Headquarter Michigan, United States
- FIGI BBG000BDCM24
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
112.53
Relación precio/flujo de caja
6.8
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1940 | URGN UroGen Pharma Ltd. - Ordinary Shares | 45.50 USD | -0.96% | -1.77% | +10.71% | +139.47% | 2.22 B USD | ||
| 1949 | AUPH Aurinia Pharmaceuticals Inc - Common Shares | 16.29 USD | -1.15% | -4.06% | +8.96% | +36.55% | 2.17 B USD | ||
| 1973 | NBTX Nanobiotix S.A. - ADSs | 42.25 USD | -6.44% | -3.96% | +12.61% | +354.30% | 2.05 B USD | ||
| 1975 | ADMA ADMA Biologics Inc - Common Stock | 9.41 USD | -0.74% | -4.85% | +8.04% | -45.92% | 2.11 B USD |